Download references

Open Access Highly Accessed

The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients

Chamaida Plasencia*, Dora Pascual-Salcedo, Sara García-Carazo, Leticia Lojo, Laura Nuño, Alejandro Villalba, Diana Peiteado, Florencia Arribas, Jesus Díez, Maria Teresa López-Casla, Emilio Martín-Mola and Alejandro Balsa

Arthritis Research & Therapy 2013, 15:R79  doi:10.1186/ar4258

Include


Format